Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURO-CBI
NCT07012629Phase 3Recruiting
- Sponsor
- Aarhus University Hospital
- Start
- Nov 2025
- Primary completion
- Sep 2031
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of aspirin, clopidogrel, rosuvastatin, atorvastatin in silent cerebral infarction (SBI), sponsored by Aarhus University Hospital. Started Nov 2025; status: recruiting.
02
Drugs
aspirinclopidogrelrosuvastatinatorvastatin
03
Conditions
silent cerebral infarction (SBI)
Beyond the preview
Go deeper on NCT07012629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012629.